Related Experiment Videos
Regenerative response in ischemic brain restricted by p21cip1/waf1
Jianhua Qiu1, Yasushi Takagi, Jun Harada
1Neuroscience Center, Harvard Medical School, Boston, MA 02129, USA.
The Journal of Experimental Medicine
|April 7, 2004
Summary
The cell cycle inhibitor p21 (p21cip1/waf1) normally restricts neural stem cell regeneration after brain injury. Removing p21 enhances neural precursor activation and neuron production, revealing a key target for brain repair.
Area of Science:
- Neuroscience
- Stem Cell Biology
- Molecular Biology
Background:
- Adult neural precursor cells exhibit high in vitro potential but limited in vivo response to brain injury.
- Constraining mechanisms limiting neural stem cell reactivity in vivo are not fully understood.
- Cell cycle inhibitors are known to restrict stem cell populations in various tissues.
Purpose of the Study:
- To investigate the role of the cell cycle inhibitor p21cip1/waf1 (p21) in limiting neural stem cell reactivity after ischemic brain injury.
- To determine if p21 restricts neural stem cell proliferation and regeneration in vivo.
Main Methods:
- Utilized p21-deficient (p21-null) mice to assess the regenerative response after ischemic brain injury.
- Analyzed neural precursor cell activation, proliferation, migration, and differentiation in the hippocampus and subventricular zone.
- Compared regenerative outcomes in p21-null mice versus wild-type controls.
Main Results:
- p21-null mice showed no increased primitive cell proliferation under steady-state conditions.
- A significantly greater proportion of quiescent neural precursors were activated in the hippocampus and subventricular zone of p21-null mice post-ischemia.
- More hippocampal precursors migrated and differentiated into neurons in p21-null mice following brain injury.
Conclusions:
- p21 acts as an intrinsic suppressor of neural regeneration following brain injury.
- p21 may function as a common molecular regulator that restricts proliferation across different stem cell pools.
- Targeting p21 could represent a novel therapeutic strategy for enhancing brain repair after injury.